Synthesis and Antimalarial Efficacy of Two-Carbon-Linked, Artemisinin-Derived Trioxane Dimers in Combination with Known Antimalarial Drugs

Citations Over TimeTop 10% of 2013 papers

Abstract

Malaria continues to be a difficult disease to eradicate largely because of the widespread populations it affects and the resistance that malaria parasites have developed against once very potent therapies. The natural product artemisinin has been a boon for antimalarial chemotherapy, as artemisinin combination therapy (ACT) has become the first line of chemotherapy. Because the threat of resistance is always on the horizon, it is imperative to continually identify new treatments, comprising both advanced analogues of all antimalarial drugs, especially artemisinin, and the exploration of novel combinations, ideally with distinct mechanisms of action. Here we report for the first time the synthesis of a series of two-carbon-linked artemisinin-derived dimers, their unique structural features, and demonstration of their antimalarial efficacy via single oral dose administration in two 60-day survival studies of Plasmodium berghei infected mice. Several of the new endoperoxide chemical entities consistently demonstrated excellent antimalarial efficacy, and combinations with two non-peroxide antimalarial drugs have been studied.

Related Papers

• → Metabolic engineering of artemisinin biosynthesis in Artemisia annua L.(2010)83 cited
• → A review of various efforts to increase artemisinin and other antimalarial compounds in Artemisia Annua L plant(2018)16 cited
• → Is Artemisinin the Only Antiplasmodial Compound in the Artemisia annua Tea Infusion? An in Vitro Study(2013)19 cited
• Self-immobilized aggreage culture of Artemisia annua L. for imroved artemisinin(2003)
• Artemisia annua glandular secretory trichomes： the biofactory of antimalarial agent artemisinin(2016)